6CHIABCD

Human cytochrome p450 17a1 in complex with inhibitor: abiraterone c6 amide
A: 273-283 B: 274-282 C: 276-278 D: 274-282
Link type Probability Loop ranges Chain A piercings Chain B piercings Chain C piercings Chain D piercings
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
view details
Other Other 35% -A +503C +503C +385D +478D +80B -400B +411B -504B
Interpreting sequences
Chain A Sequence
SLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNS---------DSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQA
Chain A Sequence
SLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSD-------QDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQA
Chain A Sequence
KSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNG-AGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAE
Chain A Sequence
KSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSD-------QDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREA
sequence length 475,475,477,474
structure length 466,468,476,467
publication title Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.
pubmed doi rcsb
molecule tags Oxidoreductase/oxidoreductase inhibitor
molecule keywords Steroid 17-alpha-hydroxylase/17,20 lyase
source organism Homo sapiens
missing residues A: 273-283 B: 274-282 C: 276-278 D: 274-282
pdb deposition date2018-02-22
LinkProt deposition date2018-06-21
Image from the rcsb pdb (www.rcsb.org)
...loading similar chains, please wait...

...loading similar chains in PDB, please wait...


 
#similar chains in the LinkProt database (?% sequence similarity)
...loading similar chains, please wait...
#similar chains, but unlinked
...loading similar chains, please wait...
#similar chains in the pdb database (?% sequence similarity)
...loading similar chains, please wait...

LinkProt | Interdisciplinary Laboratory of Biological Systems Modelling